神经炎症
化学
细胞生物学
炎症
疾病
小胶质细胞
基因表达
淀粉样蛋白(真菌学)
体内
淀粉样变性
药理学
基因
信号转导
中枢神经系统
免疫系统
神经科学
药效学
生物化学
体外
细胞
HEK 293细胞
作者
Cynthia D. Jesudason,Claudia Rangel‐Barajas,Colin J Beach,Daniel E. Beck,Isaac Caballero-Floran,Brent Clayton,Lais Da Silva,Juliane C David,Suzanne Doolen,Alexandra N. Faulkner,Adam K. Hamdani,Hasi Huhe,Kevin Huynh,Ryan D. Imhoff,June Javens‐Wolfe,Emily R. Mason,Mustapha Moussaif,Kratika Singhal,Disha M. Soni,Matilda van Buuren-Milne
标识
DOI:10.1021/acs.jmedchem.6c00010
摘要
Abstract SHIP1 is a lipid phosphatase that negatively regulates immune receptor signaling in hematopoietic cells and microglia. SAR studies guided by biochemical and cellular assays using multiple human and murine protein constructs and cells identified 3-((2-chlorobenzyl)oxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridine (32), which demonstrates SHIP1 target engagement, brain exposure, and evidence of a central pharmacodynamic response in vivo. In a protein–lipid overlay assay, compound 32 induced changes in the relative association of SHIP1 with phosphatidylinositols on a membrane surface. A thermal shift assay demonstrated cellular target engagement. Lipidomics revealed changes in the overall phosphoinositide pool consistent with target engagement and changes in phospho-AKT levels in THP-1 cells. Compound 32 enhanced uptake of myelin/membrane debris and amyloid by murine microglia, phenocopying reduced SHIP1 expression. Oral administration of 32 resulted in brain exposure sufficient to alter gene expression and reduce IL-1β levels as pharmacodynamic markers of microglial activation and neuroinflammation in an amyloidosis mouse model of Alzheimer’s disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI